Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Rapamycin
100%
Enhanced Antitumor Activity
100%
3-bromopyruvate
100%
Lung Cancer
40%
Mammalian Target of Rapamycin (mTOR)
30%
Glycolysis
20%
Non-small Cell Lung Cancer Cells
20%
Therapeutic Agents
10%
Adenosine Triphosphate
10%
Mouse Model
10%
In(III)
10%
Signaling Pathway
10%
Cell Proliferation
10%
Decreased Expression
10%
Serum Levels
10%
Alkylating Agents
10%
Antitumor Efficacy
10%
Energy Metabolism
10%
Therapeutic Strategies
10%
Alanine Aminotransferase
10%
Liver Toxicity
10%
Aspartate Aminotransferase
10%
Chemopreventive
10%
Human Lung Cancer Cell Line
10%
Tumor multiplicity
10%
Serine-threonine Kinase
10%
Mode of Delivery
10%
Dual Inhibition
10%
GAPDH
10%
Aminotransferase
10%
In Vitro Experiment
10%
Glycolytic Activity
10%
Tumor Load
10%
Systemic Distribution
10%
Cancer Chemoprevention
10%
Preventive Effect
10%
Mitochondrial Bioenergetics
10%
Aerosol Delivery
10%
Aerosol Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Antitumor Activity
100%
Lung Cancer
57%
Neoplasm
28%
Non Small Cell Lung Cancer
28%
Adenosine Triphosphate
14%
Mouse Model
14%
Alkylating Agent
14%
Aspartate Aminotransferase
14%
Alanine Aminotransferase
14%
Hepatotoxicity
14%
Casein Kinase
14%